KYORIN Pharmaceutical (4569) · InitiativeReframed
Construction of a New Formulation Development Center
First written in FY2017. 1 of 2 entries say "Reframed", first in FY2018. Latest entry: FY2018.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Construction of a New Formulation Development CenterA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2018ReframedAnnual report
「For the fiscal year ending March 2019, we planned to spend approximately ¥4 billion on the acquisition of fixed assets, including the expansion of factory facilities.」
The plan changed from construction of the New Formulation Development Center to a fixed-asset investment plan focused on expanding production facilities and other projects in the following fiscal year. - FY2017First statedAnnual report
「For the fiscal year ending March 2018, we planned capital expenditures of approximately ¥4.3 billion, including construction of a new formulation development center.」
A plan was announced to spend approximately ¥4.3 billion on construction of a new formulation development center and other fixed assets in the fiscal year ending March 2018.